Amphix Bio

About Amphix Bio

Amphix Bio is a regenerative medicine company focused on developing therapeutics that promote healing after traumatic injury and increase human healthspan, the period during which people can live productive and fulfilling lives.

Products & Services

Supramolecular Therapeutic Peptide (STP) Platform:A transformative platform using supramolecular chemistry to activate regenerative signals, create scaffolds for tissue growth, and enable effective cell and tissue regeneration without the challenges of cell therapies.

AMFX-200 Series (Neurological Regeneration):Programs targeting acute and chronic spinal cord injury, ischemic stroke, ALS, Parkinson's disease, and neuropathy, with candidates in various stages from discovery to Phase 1.

AMFX-100 Series (Musculoskeletal Regeneration):Programs targeting degenerative disc disease and articular cartilage injury, with candidates in development stages.

Specialties

Supramolecular Chemistry Regenerative Therapeutics Neurological Regeneration Musculoskeletal Regeneration Peptide-Based Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: SBIR Phase II Grant T: - FT: SBIR Phase II Grant	A: 1000000 MR: - FA: $1M FAN: 1000000	D: 2024-10-31 FD: 2024-10-31	2 investors

SBIR Phase II Grant Latest

2024-10-31

$1.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

N

Nick Sather

Co-founder & Chief Executive Officer

C

Charlotte Chen

Principal Scientist

W

Wellington Hsu

Scientific Advisor, Clinical Studies

D

Daniel Allar

Communications Specialist

S

Samuel Stupp

Board of Trustees Professor of Materials Science and Engineering, Chemistry, Medicine and Biomedical Engineering

I

Iwona Maciagiewicz

Principal Scientist

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Amphix Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised